Effect of Angiotensin II Receptor Antagonism on Cerebral Vasomotor Reserve in Humans

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 6, 2003, Pages 714-718

  Fu, Chin Hua ^a   Yang, Cheryl C H ^b   Kuo, Terry B J ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Cerebral autoregulation; Frequency domain analysis; Transcranial Doppler

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; VALSARTAN; VOLSARTANE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFRACTION; DOPPLER ECHOGRAPHY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; FLOW RATE; FREQUENCY ANALYSIS; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL;

ADULT; AGED; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CEREBRAL ARTERIES; FEMALE; HOMEOSTASIS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 0345448299     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200312000-00004     Document Type: Article

References (26)

1. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev. 1959;39:183-238.
2. Aaslid R, Lindergaard KF, Sorteberg W, et al. Cerebral autoregulation dynamics in humans. Stroke. 1989;20:45-52.
3. Tiecks FP, Lam AM, Aaslid R, et al. Comparison of static and dynamic cerebral autoregulation measurements. Stroke. 1995;26:1014-1019.
4. Blaber AP, Bondar RL, Stein F, et al. Transfer function analysis of cerebral autoregulation dynamics in autonomic failure patients. Stroke. 1997;28:1686-1692.
5. Zhang R, Zuckerman JH, Giller CA, et al. Transfer function analysis of dynamic cerebral autoregulation in humans. Am J Physiol. 1998;274: H233-H241.
6. Kuo TBJ, Chern CM, Sheng WY, et al. Frequency domain analysis of cerebral blood flow velocity and its correlation with arterial blood pressure. J Cereb Blood Flow Metab. 1998;18:311-318.
7. Hu HH, Kuo TBJ, Wong WJ, et al. Transfer function analysis of cerebral hemodynamics in patients with carotic stenosis. J Cereb Blood Flow Metab. 1999;19:460-465.
8. Paulson OB, Vorstrup S, Andersen AR, et al. Converting enzyme inhibition resets cerebral autoregulation at lower blood pressure. J Hypertens. 1985;3(Suppl 3):S487-S488.
9. Sadoshima S, Nagao T, Ibayashi S, et al. Inhibition of antiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats. Hypertension. 1994;23:781-785.
10. Timmermans PBMWM, Inagami I, Saavedra JM, et al. Angiotensin receptor subtypes and their pharmacology. In: Cuello AC, Collier B, eds. Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990's. Basel, Switzerland: Birkhauser Verlag; 1995:37-58.
11. Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke. 2000;31:2478-2486.
12. Kuo TBJ, Yien HW, Hseu SS, et al. Diminished vasomotor component of systemic arterial pressure signals and baroreflex in brain death. Am J Physiol. 1997;273:H1291-H1298.
13. Stearns SD, David RA. Signal Processing Algorithms. Englewood Cliffs, NJ: Prentice-Hall; 1988.
14. Kuo TBJ, Yang CCH, Chan SHH. Selective activation of vasomotor component of SAP spectrum by nucleus reticularis ventrolateralis in rats. Am J Physiol. 1997;272:H485-H492.
15. De Boer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol. 1987;253:H680-H689.
16. Yang CCH, Kuo TBJ. Assessment of cardiac sympathetic regulation by respiratory-related arterial pressure variability in the rat. J Physiol (Lond). 1999;515:887-896.
17. Kuo TBJ, Yang CCH, Chan SHH. Transfer function analysis of ventilatory infulence on systemic arterial pressure in the rat. Am J Physiol. 1996;271:H2108-H2115.
18. Malliani A, Pagani M, Lombardi F, et al. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482-492.
19. Galust'ian GE, Gavrikov KE. The variability characteristics of the arterial pressure in men and animals. Usp Fiziol Nauk. 1999;30:67-80.
20. Hajdu MA, Heistad DD, Ghoneim S, et al. Effects of antihypertensive treatment on composition of cerebral arterioles. Hypertension. 1991;18(Suppl II):1115-1121.
21. Vraamak T, Waldemar G, Strandgaard S, et al. Angiotensin II receptor antagonist candesartan and cerebral blood flow autoregulation. J Hypertens. 1995;13:755-761.
22. Squire IB. Actions of angiotensin II on cerebral blood flow autoregulation in health and disease. J Hypertens. 1994;12:1203-1208.
23. Nishimura Y, Xu T, Johren O, et al. The angiotensin AT1 receptor antagonist candesartan regulates cerebral blood flow and brain angiotensin AT1 receptor expression. Basic Res Cardiol. 1998;93(Suppl 2):63-68.
24. Toole JF. Cerebrovascular Disorders. New York, NY: Raven Press; 1984.
25. Aaslid R, Newell DW, Stooss R, et al. Assessment of cerebral autoregulation dynamic by simultaneous arterial and venous transcranial Doppler. Stroke. 1991;22:1148-1154.
26. Newell DW, Aaslid R, Lam AM, et al. Comparison of flow and velocity during dynamic autoregulation testing in humans. Stroke. 1994;25:793-797.